Nordhealth Future Growth

Future criteria checks 1/6

Nordhealth is forecast to grow earnings and revenue by 55.4% and 15.3% per annum respectively while EPS is expected to grow by 51.4% per annum.

Key information

55.4%

Earnings growth rate

51.4%

EPS growth rate

Healthcare Services earnings growth26.0%
Revenue growth rate15.3%
Future return on equityn/a
Analyst coverage

Low

Last updated10 Sep 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:6E5 - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202552-4N/AN/A1
12/31/202446-8N/AN/A1
6/30/202441-9-7-2N/A
3/31/202438-10-8-3N/A
12/31/202337-11-11-5N/A
9/30/202335-12-11-4N/A
6/30/202334-14-13-6N/A
3/31/202333-15-12-5N/A
12/31/202231-14-13-6N/A
9/30/202229-12-8-2N/A
6/30/202227-10-41N/A
3/31/202224-8-13N/A
12/31/202120-526N/A
9/30/202118-2N/AN/AN/A
6/30/2021150N/AN/AN/A
3/31/2021132N/AN/AN/A
12/31/2020132N/AN/AN/A
12/31/20198-1N/AN/AN/A
12/31/20185-1N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 6E5 is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 6E5 is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 6E5 is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 6E5's revenue (15.3% per year) is forecast to grow faster than the German market (5.5% per year).

High Growth Revenue: 6E5's revenue (15.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 6E5's Return on Equity is forecast to be high in 3 years time


Discover growth companies